Helper-free Production of Laboratory Grade AAV and Purification by lodixanol Density Gradient Centrifugation

被引:58
作者
Crosson, Sean M. [1 ]
Dib, Peter [2 ]
Smith, J. Kennon [3 ]
Zolotukhin, Sergei [1 ]
机构
[1] Univ Florida, Div Cell & Mol Therapy, Dept Pediat, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
来源
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2018年 / 10卷
关键词
GENE-TRANSFER; OPEN-LABEL; SAFETY; TITER; SEROTYPE-2; DYSTROPHY; EFFICACY; VECTORS; THERAPY; CELLS;
D O I
10.1016/j.omtm.2018.05.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Adeno-associated virus (AAV) is one of the most promising gene therapy vectors and is widely used as a gene delivery vehicle for basic research. As AAV continues to become the vector of choice, it is increasingly important for new researchers to have access to a simplified production and purification protocol for laboratory grade recombinant AAV. Here we report a detailed protocol for serotype independent production of AAV using a helper-free HEK293 cell system followed by iodixanol gradient purification, a method described earlier. While the core principals of this mammalian AAV production system are unchanged, there have been significant advancements in the production and purification procedure that serve to boost yield, maximize efficiency, and increase the purity of AAV preps. Using this protocol, we are able to constantly obtain high quantities of laboratory grade AAV particles (>5 x 10(12) vg) in a week's time, largely independent of serotype.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 18 条
  • [1] Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids
    Booth, MJ
    Mistry, A
    Li, X
    Thrasher, A
    Coffin, RS
    [J]. GENE THERAPY, 2004, 11 (10) : 829 - 837
  • [2] Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
    Bowles, Dawn E.
    McPhee, Scott W. J.
    Li, Chengwen
    Gray, Steven J.
    Samulski, Jade J.
    Camp, Angelique S.
    Li, Juan
    Wang, Bing
    Monahan, Paul E.
    Rabinowitz, Joseph E.
    Grieger, Joshua C.
    Govindasamy, Lakshmanan
    Agbandje-McKenna, Mavis
    Xiao, Xiao
    Samulski, R. Jude
    [J]. MOLECULAR THERAPY, 2012, 20 (02) : 443 - 455
  • [3] A fluorescence video-endoscopy technique for detection of gene transfer and expression
    Flotte, TR
    Beck, SE
    Chesnut, K
    Potter, M
    Poirier, A
    Zolotukhin, S
    [J]. GENE THERAPY, 1998, 5 (02) : 166 - 173
  • [4] Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector
    Grieger, Joshua C.
    Soltys, Stephen M.
    Samulski, Richard Jude
    [J]. MOLECULAR THERAPY, 2016, 24 (02) : 287 - 297
  • [5] Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer
    Hildinger, M
    Auricchio, A
    Gao, G
    Wang, L
    Chirmule, N
    Wilson, JM
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (13) : 6199 - 6203
  • [6] Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
    Kaplitt, Michael G.
    Feigin, Andrew
    Tang, Chengke
    Fitzsimons, Helen L.
    Mattis, Paul
    Lawlor, Patricia A.
    Bland, Ross J.
    Young, Deborah
    Strybing, Kristin
    Eidelberg, David
    During, Matthew J.
    [J]. LANCET, 2007, 369 (9579) : 2097 - 2105
  • [7] Safety and efficacy of gene transfer for Leber's congenital amaurosis
    Maguire, Albert M.
    Simonelli, Francesca
    Pierce, Eric A.
    Pugh, Edward N., Jr.
    Mingozzi, Federico
    Bennicelli, Jeannette
    Banfi, Sandro
    Marshall, Kathleen A.
    Testa, Francesco
    Surace, Enrico M.
    Rossi, Settimio
    Lyubarsky, Arkady
    Arruda, Valder R.
    Konkle, Barbara
    Stone, Edwin
    Sun, Junwei
    Jacobs, Jonathan
    Dell'Osso, Lou
    Hertle, Richard
    Ma, Jian-xing
    Redmond, T. Michael
    Zhu, Xiaosong
    Hauck, Bernd
    Zelenaia, Olga
    Shindler, Kenneth S.
    Maguire, Maureen G.
    Wright, J. Fraser
    Volpe, Nicholas J.
    McDonnell, Jennifer Wellman
    Auricchio, Alberto
    High, Katherine A.
    Bennett, Jean
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (21) : 2240 - 2248
  • [8] Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
    Manno, CS
    Arruda, VR
    Pierce, GF
    Glader, B
    Ragni, M
    Rasko, J
    Ozelo, MC
    Hoots, K
    Blatt, P
    Konkle, B
    Dake, M
    Kaye, R
    Razavi, M
    Zajko, A
    Zehnder, J
    Nakai, H
    Chew, A
    Leonard, D
    Wright, JF
    Lessard, RR
    Sommer, JM
    Tigges, M
    Sabatino, D
    Luk, A
    Jiang, HY
    Mingozzi, F
    Couto, L
    Ertl, HC
    High, KA
    Kay, MA
    [J]. NATURE MEDICINE, 2006, 12 (03) : 342 - 347
  • [9] OneBac: Platform for Scalable and High-Titer Production of Adeno-Associated Virus Serotype 1-12 Vectors for Gene Therapy
    Mietzsch, Mario
    Grasse, Sabrina
    Zurawski, Catherine
    Weger, Stefan
    Bennett, Antonette
    Agbandje-McKenna, Mavis
    Muzyczka, Nicholas
    Zolotukhin, Sergei
    Heilbronn, Regine
    [J]. HUMAN GENE THERAPY, 2014, 25 (03) : 212 - 222
  • [10] Development of a Rapid, Robust, and Universal PicoGreen-Based Method to Titer Adeno-Associated Vectors
    Piedra, Jose
    Ontiveros, Maria
    Miravet, Susana
    Penalva, Cristina
    Monfar, Merce
    Chillon, Miguel
    [J]. HUMAN GENE THERAPY METHODS, 2015, 26 (01) : 35 - 42